Discover the latest strides in the realm of Treatment Resistant Depression (TRD) research in our latest blog. Join Dr. Iain Jordan, our Clinical Director, as he provides a comprehensive overview, delving into discussions on current treatments and unveiling the cutting-edge clinical research underway at Clerkenwell Health.

In recent years, significant strides have been made in the medical field regarding treatments for post-traumatic stress disorder (PTSD), notably in the use of entactogens like MDMA (commonly known as ecstasy) and methylone to aid therapy. For individuals whose lives have been profoundly impacted by PTSD, these advancements offer additional options, especially when traditional treatments like psychotherapy and medication are not enough.   

In most countries, clinical trials are the only way to receive psychedelic therapy in a medical setting. If you’re interested in participating in one but not sure how, this guide will walk you through what you need to know.